December 12, 2024 16:41 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked
Fighting COVID-19: New Zealand secures another medicine

Fighting COVID-19: New Zealand secures another medicine

Nov 05, 2021, at 09:58 pm

Wellington/UNI/Xinhua: The addition of another drug to the suite of COVID-19 medicines available in New Zealand is good news for patients and for the health system, Health Minister Andrew Little said on Friday.

Dr Reddy Labs enters in voluntary licensing agreement with Eli Lilly to access it’s Covid treatment in India

Dr Reddy Labs enters in voluntary licensing agreement with Eli Lilly to access it’s Covid treatment in India

May 12, 2021, at 09:48 pm

Hyderabad/UNI: Dr Reddy’s Laboratories on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (“Lilly”) for the manufacture and commercialization of the drug Baricitinib in India.